Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy.
about
Current and emerging treatment strategies for Duchenne muscular dystrophyCell-type specific penetrating peptides: therapeutic promises and challengesSmall mammalian animal models of heart diseaseDystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel TherapiesPharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsProtein engineering of the N-terminus of NEMO: structure stabilization and rescue of IKKβ binding.VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.Emerging drugs for Duchenne muscular dystrophyWasting mechanisms in muscular dystrophy.Myocardial Contractile Dysfunction Is Present without Histopathology in a Mouse Model of Limb-Girdle Muscular Dystrophy-2F and Is Prevented after Claudin-5 Virotherapy.Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophyAutophagy downregulation contributes to insulin resistance mediated injury in insulin receptor knockout podocytes in vitro.Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.PGC-1α gene transfer improves muscle function in dystrophic muscle following prolonged disease progress.Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscleA Synthetic Loop Replacement Peptide That Blocks Canonical NF-κB Signaling.Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype.NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model
P2860
Q26741535-2D610857-BACA-4BF4-9C08-0DF99EC6DCA7Q26800103-90E37E2B-CA5A-444E-A4C3-614EDCAF23CAQ28068860-D8699967-CB09-4B0B-9EC6-37F3A22BB696Q33608478-8712A13E-783D-415B-BCA6-D037B1B0D9BDQ34152280-10549626-8050-468C-B161-B5183B24DA47Q34463911-1B6DECDA-94E5-40FA-824D-A93142E72C6BQ34981147-62BA0740-51A7-4C8D-A023-C7A45BBF9E47Q35190356-910BBBE1-2918-4E9D-B479-91CC9A981674Q36363716-76140B74-267A-4C47-BC32-212DB629C878Q37138490-2184C7A1-4ADE-4E7C-BB9D-783F09F097B6Q37474934-F139F164-73D2-434D-9E51-FCA1224B0E09Q39410461-AB66CAD4-F232-40FD-981C-E70D9EEC09B2Q40124684-677F07FC-BC88-41C4-872F-C50766E4A2C1Q40402014-FD87E15B-BD58-45E7-BEEB-7FD20E8A17F3Q41487839-800B364D-66CB-429F-8D93-D628E76CC84FQ42350965-A1E65C77-22A3-4B03-9487-3F938C61451DQ43402247-30519488-2E41-45D2-8479-DAA30E38356CQ49428049-F026B464-A0E0-4EC5-B7FF-93AB5C171666Q58707771-8C9E1673-9960-4215-A196-3810A2A9C97F
P2860
Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Improvement of cardiac contrac ...... e model of muscular dystrophy.
@ast
Improvement of cardiac contrac ...... e model of muscular dystrophy.
@en
type
label
Improvement of cardiac contrac ...... e model of muscular dystrophy.
@ast
Improvement of cardiac contrac ...... e model of muscular dystrophy.
@en
prefLabel
Improvement of cardiac contrac ...... e model of muscular dystrophy.
@ast
Improvement of cardiac contrac ...... e model of muscular dystrophy.
@en
P2093
P2860
P356
P1476
Improvement of cardiac contrac ...... e model of muscular dystrophy.
@en
P2093
Dawn A Delfín
Denis C Guttridge
Jennifer M Peterson
Jill A Rafael-Fortney
Paul Ml Janssen
P2860
P2888
P356
10.1186/1479-5876-9-68
P577
2011-05-17T00:00:00Z
P5875
P6179
1050377469